Lung ablation: Whats new?

Journal of Thoracic Imaging

Volumn 31, Issue 4, 2016, Pages 228-237

  Xiong, Lillian ^a   Dupuy, Damian E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Lung ablation; Radiofrequency ablation; Technique; Tumor ablation

Indexed keywords

ABLATION THERAPY; CONFERENCE PAPER; CRYOABLATION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; IRREVERSIBLE ELECTROPORATION; LUNG ABLATION; MEDICAL RESEARCH; MICROWAVE THERMOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; RADIOFREQUENCY ABLATION; THERMAL ABLATION; TUMOR ABLATION; CATHETER ABLATION; LUNG; LUNG NEOPLASMS; PROCEDURES; TREATMENT OUTCOME; TRENDS;

CATHETER ABLATION; HUMANS; LUNG; LUNG NEOPLASMS; TREATMENT OUTCOME;

EID: 84962384879     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0000000000000212     Document Type: Conference Paper

References (52)

1. American Cancer Society. What Are The Key Statistics on Lung Cancer? American Cancer Society, March 4, 2015 [cited 2015 August 1, 2015].
2. Mazzone P. Preoperative evaluation of the lung resection candidate. Cleve Clin J Med. 2012;79 (electronic suppl 1): eS17-eS22.
3. Jain SK, Dupuy DE, Cardarelli GA, et al. Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy. Am J Roentgenol. 2003;181: 711-715.
4. Ruers T, Punt CJ, van Coevorden F, et al. Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM). ASCO Annual Meeting, 2010.
5. Suh R, Reckamp K, Zeidler M, et al. Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park). 2005;19(suppl 4):12-21.
6. Dupuy DE, Mayo-Smith WW, Abbott GF, et al. Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics. 2002;22:S259-S269.
7. Alexander ES, Healey TT, Martin DW, et al. Use of endobronchial valves for the treatment of bronchopleural fistulas after thermal ablation of lung neoplasms. J Vasc Interv Radiol. 2012;23:1236-1240.
8. VanSonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience - technical and multidisciplinary considerations in 30 patients. Am J Roentgenol. 2005;184:381-390.
9. Kawamura M, Izumi Y, Tsukada N, et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg. 2006;131: 1007-1013.
10. Solomon SB, Thornton RH, Dupuy DE, et al. Protection of the mediastinum and chest wall with an artificial pneumothorax during lung ablations. J Vasc Interv Radiol. 2008;19: 610-615.
11. McTaggart RA, Dupuy DA, Dipetrillo T. Image guided ablation in the thorax. In: Geschwind J-FH, Soulen MC, eds. Interventional Oncology: Principles and Practice. Cambridge, UK: Cambridge University Press; 2008.
12. Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities - part I. J Vasc Interv Radiol. 2001;12:1021-1032.
13. Beland MDD, Damian E. Current and future applications of percutaneous radiofrequency ablation in the treatment of lung neoplasms. Appl Radiol. 2006;35:21-28.
14. Gage AA, Baust JM, Baust JG. Experimental cryosurgery investigations in vivo. Cryobiology. 2009;59:229-243.
15. Hinshaw JL, Lee FT Jr., Laeseke PF, et al. Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation. J Vasc Interv Radiol. 2010;21: 1424-1428.
16. Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol. 2013;16: 192-200.
17. Scheffer HJ, Nielsen K, de Jong MC, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol. 2014;25:997-1011. quiz 1011.
18. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality - clinical implications. Technol Cancer Res Treat. 2007;6:37-48.
19. McTaggart RA, Dupuy DE. Thermal ablation of lung tumors. Tech Vasc Interv Radiol. 2007;10:102-113.
20. Pech M, Janitzky A, Wendler JJ, et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol. 2011;34:132-138.
21. Silk M, Tahour D, Srimathveeravalli G, et al. The state of irreversible electroporation in interventional oncology. Semin Interv Radiol. 2014;31:111-117.
22. Suh RD, Wallace AB, Sheehan RE, et al. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation - preliminary results. Radiology. 2003;229: 821-829.
23. Chheang S, Abtin F, Guteirrez A, et al. Imaging features following thermal ablation of lung malignancies. Semin Interv Radiol. 2013;30:157-168.
24. Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. Am J Roentgenol. 2004;183:361-368.
25. Jin GY, Lee JM, Lee YC, et al. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. Am J Roentgenol. 2004;183:1013-1020.
26. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology. 2000;214: 73-80.
27. Higuchi M, Honjo H, Shigihara T, et al. A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET. J Cancer Res Clin Oncol. 2014; 140:1957-1963.
28. Bonichon F, Palussiere J, Godbert Y, et al. Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study. Eur J Nucl Med Mol Imaging. 2013;40:1817-1827.
29. Yoo DC, Dupuy DE, Hillman SL, et al. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? Am J Roentgenol. 2011;197:334-340.
30. Wolf FJ, Grand DJ, Machan JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247:871-879.
31. Ito N, Nakatsuka S, Inoue M, et al. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. J Vasc Interv Radiol. 2012;23:1043-1052.
32. Thomson KR, Cheung W, Ellis SJ, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol. 2011;22:611-621.
33. de Baere T, Tselikas L, Woodrum D, et al. Evaluating cryoablation of metastatic lung tumors in patients-safety and efficacy: The ECLIPSE trial-interim analysis at 1-year. J Thorac Oncol. 2015;10:1468-1474.
34. Dupuy DE, Fernando HC, Hillman S, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer. 2015;121:3491-3498.
35. Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(suppl):e278S-e313S.
36. Brace CL, Hinshaw JL, Laeseke PF, et al. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology. 2009;251:705-711.
37. Dupuy DE. Microwave ablation compared with radiofrequency ablation in lung tissue-is microwave not just for popcorn anymore? Radiology. 2009;251:617-618.
38. Simon CJ, Dupuy DE, Mayo-Smith WW.Microwave ablation: principles and applications. Radiographics. 2005;25(suppl 1): S69-S83.
39. Goldberg SN, Gazelle GS, Solbiati L, et al. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol. 1996;3:636-644.
40. Belfiore G, Ronza F, Belfiore MP, et al. Patients' survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol. 2013;82:177-181.
41. Palussiere J, Lagarde P, Auperin A, et al. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers. Cardiovasc Intervent Radiol. 2015;38:160-166.
42. Wang H, Littrup PJ, Duan Y, et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289-298.
43. Maiwand MO. The role of cryosurgery in palliation of tracheobronchial carcinoma. Eur J Cardiothorac Surg. 1999;15: 764-768.
44. Yashiro H, Nakatsuka S, Inoue M, et al. Factors affecting local progression after percutaneous cryoablation of lung tumors. J Vasc Interv Radiol. 2013;24:813-821.
45. Moore W, Talati R, Bhattacharji P, et al. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol. 2015;26: 312-319.
46. Dupuy DE, Aswad B, Ng T. Irreversible electroporation in a Swine lung model. Cardiovasc Intervent Radiol. 2011;34: 391-395.
47. Ricke J, Jurgens JH, Deschamps F, et al. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc Intervent Radiol. 2015;38:401-408.
48. Ghosh S, Sujendran V, Alexiou C, et al. Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy (CHART) in patients aged >70 years with stage 1 non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;24: 1002-1007.
49. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45: 787-795.
50. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:1070-1076.
51. Kwan SW, Mortell KE, Talenfeld AD, et al. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer. J Vasc Interv Radiol. 2014;25:1-9.e1.
52. Kwan SW, Mortell KE, Hippe DS, et al. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer. J Vasc Interv Radiol. 2014;25: 1558-1564. quiz 1565.